Commercializing a Dedicated
Breast CT Platform for the Earlier Detection, Diagnosis and Treatment of
Breast Cancers

“Izotropic has conducted significant technical, clinical and market-positioning efforts that provide a high level of confidence that the final product will meet patient, physician and marketplace requirements.”

-StarFish Medical Founder and CEO Scott Phillips

Latest News